Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities

ICICI Securities has come out with its first quarter (April - June’ 26) earnings estimates for the Pharma sector. The brokerage house expects Biocon to report net profit at Rs 91.1 crore down 72% year-on-year (up 116.2% quarter-on-quarter).

Net Sales are expected to decrease by 9.8 percent Y-o-Y (up 16.1 percent Q-o-Q) to Rs 3,984.5 crore, according to ICICI Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 25.4 percent Y-o-Y (up 29.7 percent Q-o-Q) to Rs 804.9 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

ICICI_Pharma